Two-component dental material applicator, manual Australia - English - Department of Health (Therapeutic Goods Administration)

two-component dental material applicator, manual

3m australia pty ltd - 60885 - two-component dental material applicator, manual - a non-sterile, manual, hand-held device intended to dispense a two-component dental material (e.g., impression material) from a cartridge directly into the mouth or into another device (e.g., impression tray).

AMDARONE amiodarone hydrochloride 200 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

amdarone amiodarone hydrochloride 200 mg tablet blister pack

sanofi-aventis australia pty ltd - amiodarone hydrochloride, quantity: 200 mg - tablet, uncoated - excipient ingredients: povidone; maize starch; lactose monohydrate; colloidal anhydrous silica; magnesium stearate - severe cases of tachyarrhythmias (eg. wolff-parkinson-white syndrome, supraventricular, nodal and ventricular tachycardias, atrial flutter and fibrillation, ventricular fibrillation) not responding to other therapy. treatment should be initiated in hospital. it is recommended that the patient should be regularly monitored for possible toxicity (eg. thyroid function, chest x-ray, ophthalmological examination, liver function etc.) during the entire course of therapy and for several months after discontinuation.

Two-component dental material applicator, electric Australia - English - Department of Health (Therapeutic Goods Administration)

two-component dental material applicator, electric

numedical pty ltd - 62681 - two-component dental material applicator, electric - a battery-powered device intended to dispense a two component dental material (e.g., impression material) from a cartridge directly into the mouth or into another device (e.g., impression tray). it is handpiece with an electric cartridge-plunging mechanism; typically, a dental material mixing nozzle is attached to the distal tip of the cartridge during use. this is a reusable device after appropriate cleaning

OSSIX Bone - Dental bone matrix implant, synthetic Australia - English - Department of Health (Therapeutic Goods Administration)

ossix bone - dental bone matrix implant, synthetic

dentsply sirona pty ltd - 47971 - dental bone matrix implant, synthetic - a spongy, porous scaffold composed of collagenized hydroxyapatite at a mass ratio of 20% collagen and 80% the inorganic mineral particles. the collagen prevents migration of the hydroxyapatite particles and facilitates adaptation to the defect site. the macro and microporous structure of the scaffold allow the infiltration of the bone forming cells, ingrowth of new bone at the implantation and eventually bone remodeling by osteoclasts and osteoblasts. an osteoconductive bone grafting material aimed to fill, augment, or reconstruct periodontal and bony defects of the maxillo-facial complex.

Two-component dental material applicator, manual Australia - English - Department of Health (Therapeutic Goods Administration)

two-component dental material applicator, manual

kulzer australia pty ltd - 60885 - two-component dental material applicator, manual - a non-sterile, manual, hand-held device intended to dispense a two-component dental material from a cartridge directly into the mouth or into another device.

CORDARONE X 100 amiodarone hydrochloride 100mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

cordarone x 100 amiodarone hydrochloride 100mg tablet blister pack

sanofi-aventis australia pty ltd - amiodarone hydrochloride, quantity: 100 mg - tablet, uncoated - excipient ingredients: maize starch; magnesium stearate; lactose monohydrate; povidone; colloidal anhydrous silica - severe cases of tachyarrhythmias (eg. wolff-parkinson-white syndrome, supraventricular, nodal and ventricular tachycardias, atrial flutter and fibrillation, ventricular fibrillation) not responding to other therapy. treatment should be initiated in hospital. it is recommended that the patient should be regularly monitored for possible toxicity (eg. thyroid function, chest x-ray, ophthalmological examination, liver function etc.) during the entire course of therapy and for several months after discontinuation.